XML 30 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2020
Stockholders' Equity Note [Abstract]  
Share-based Compensation, Stock Options, Activity
A summary of employees’ stock options activities during the six months ended June 30, 2020 is as follows:
 
 Six Months Ended
June 30, 2020 (unaudited)
 NumberWeighted
average
exercise price
Aggregate
intrinsic value
(in thousands)
Weighted average
remaining
contractual life
(years)
Options outstanding as of January 1, 2020454,348  $20.628  $25,935  4.343
Granted—  $—  
Exercised(64,005) $19.991  
Forfeited and expired(500) $1.576  
Options outstanding and exercisable as of June 30, 2020389,843  $20.757  $26,401  3.925
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range The options outstanding as of June 30, 2020 (unaudited) have been separated into ranges of exercise price as follows:
Range of exercise priceOptions outstanding
and exercisable as of
June 30, 2020
Weighted average remaining contractual life (years)Weighted average exercise price of options outstanding and exercisable
$6.230  8.80010,856  1.566  $8.216  
$12.470  16.870109,838  3.621  $14.232  
$19.510  21.660147,900  4.127  $21.158  
$22.010  24.23054,367  3.807  $22.277  
 $29.88053,088  4.647  $29.880  
 $39.86013,794  3.726  $39.860  
   389,843  3.925  $20.757  
Schedule of Stockholders' Equity Note, Warrants or Rights
The Company’s outstanding options granted to consultants for services as of June 30, 2020 (unaudited) were as follows:
 
 Options outstanding and exercisable as of June 30, 2020Exercise price
per share
Exercisable
through
 (number)  
February 20131,500  $12.470  February 2023
August 20134,000  $21.140  August 2023
March 20142,700  $39.860  March 2024
May 20143,700  $22.010  May 2024
November 20144,038  $21.660  November 2024
May 20151,057  $19.510  May 2025
February 20161,950  $16.870  February 2026
 18,945    
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
A summary of restricted stock units and performance stock units for employees, consultants and non-employee directors of the Company for the six months ended June 30, 2020 (unaudited) is as follows:
 
 Number of
shares underlying
outstanding
restricted stock units
Weighted-
average
grant date
fair value
Unvested balance - January 1, 20202,559,083  $49.58  
Granted1,296,911  $84.52  
Vested(833,037) $43.77  
Forfeited(131,362) $59.87  
Unvested balance – June 30, 20202,891,595  $66.46  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
The Company recognized non-cash stock-based compensation expense in the consolidated statements of operations as follows:
 
 Three Months Ended
June 30,
Six Months Ended
June 30,
 2020201920202019
(unaudited)
(in thousands)
(unaudited)
(in thousands)
Cost of revenues$1,354  $772  $2,139  $1,330  
Research and development5,686  3,520  9,767  6,198  
Sales and marketing6,860  3,640  11,589  7,083  
General and administrative3,723  6,864  7,011  9,146  
Total$17,623  $14,796  $30,506  $23,757